TSX:PRM (Canada)  
Big Pharma Split Corp logo

Big Pharma Split Corp

C$ 12.90 (-1.23%) Sep 23
P/E:
5.32
P/B:
0.82
Market Cap:
C$ 19.53M ($ 14.36M)
Enterprise V:
C$ 18.61M ($ 13.68M)
Volume:
1.88K
Avg Vol (2M):
2.73K
Volume:
1.88K
Market Cap C$:
19.53M
Market Cap $:
14.36M
PE Ratio:
5.32
Avg Vol (2-Month):
2.73K
Enterprise Value C$:
18.61M
Enterprise Value $:
13.68M
PB Ratio:
0.82
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.6
Debt-to-EBITDA N/A
N/A
N/A
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 28.36
9-Day RSI 29.88
14-Day RSI 31.05
6-1 Month Momentum % -6.62
12-1 Month Momentum % 1.58

Liquidity Ratio

Name Current Vs Industry Vs History

Financials

TSX:PRM's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 4.964
EPS (TTM) (C$) 2.43
Beta 0.99
Volatility % 19.89
14-Day RSI 31.05
14-Day ATR (C$) 0.288833
20-Day SMA (C$) 13.3405
12-1 Month Momentum % 1.58
52-Week Range (C$) 12.83 - 16.77
Shares Outstanding (Mil) 1.51

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Big Pharma Split Corp Filings

Document Form Filing Date
No Filing Data

Big Pharma Split Corp Analysis

Share your research